189 related articles for article (PubMed ID: 24363078)
1. Long-lasting sensitization induced by repeated risperidone treatment in adolescent Sprague-Dawley rats: a possible D2 receptor mediated phenomenon?
Qiao J; Gao J; Shu Q; Zhang Q; Hu G; Li M
Psychopharmacology (Berl); 2014 Apr; 231(8):1649-1659. PubMed ID: 24363078
[TBL] [Abstract][Full Text] [Related]
2. Time-dependence of risperidone and asenapine sensitization and associated D2 receptor mechanism.
Gao J; Li M
Behav Brain Res; 2013 Nov; 257():286-94. PubMed ID: 24103641
[TBL] [Abstract][Full Text] [Related]
3. Repeated administration of aripiprazole produces a sensitization effect in the suppression of avoidance responding and phencyclidine-induced hyperlocomotion and increases D2 receptor-mediated behavioral function.
Gao J; Qin R; Li M
J Psychopharmacol; 2015 Apr; 29(4):390-400. PubMed ID: 25586399
[TBL] [Abstract][Full Text] [Related]
4. Long-term impacts of adolescent risperidone treatment on behavioral responsiveness to olanzapine and clozapine in adulthood.
Qiao J; Zhang Q; Li M
Prog Neuropsychopharmacol Biol Psychiatry; 2014 Jan; 48():177-85. PubMed ID: 24140929
[TBL] [Abstract][Full Text] [Related]
5. Asenapine sensitization from adolescence to adulthood and its potential molecular basis.
Shu Q; Qin R; Chen Y; Hu G; Li M
Behav Brain Res; 2014 Oct; 273():166-76. PubMed ID: 25093543
[TBL] [Abstract][Full Text] [Related]
6. Olanzapine sensitization and clozapine tolerance: from adolescence to adulthood in the conditioned avoidance response model.
Qiao J; Li H; Li M
Neuropsychopharmacology; 2013 Feb; 38(3):513-24. PubMed ID: 23132270
[TBL] [Abstract][Full Text] [Related]
7. Repeated asenapine treatment produces a sensitization effect in two preclinical tests of antipsychotic activity.
Qin R; Chen Y; Li M
Neuropharmacology; 2013 Dec; 75():356-64. PubMed ID: 23954676
[TBL] [Abstract][Full Text] [Related]
8. Effects of Repeated Ropinirole Treatment on Phencyclidine-Induced Hyperlocomotion, Prepulse Inhibition Deficits, and Social Avoidance in Rats.
Maple AM; Call T; Kimmel PC; Hammer RP
J Pharmacol Exp Ther; 2017 Apr; 361(1):109-114. PubMed ID: 28167638
[TBL] [Abstract][Full Text] [Related]
9. Olanzapine and risperidone disrupt conditioned avoidance responding in phencyclidine-pretreated or amphetamine-pretreated rats by selectively weakening motivational salience of conditioned stimulus.
Li M; He W; Mead A
Behav Pharmacol; 2009 Feb; 20(1):84-98. PubMed ID: 19179852
[TBL] [Abstract][Full Text] [Related]
10. Adult response to olanzapine or clozapine treatment is altered by adolescent antipsychotic exposure: a preclinical test in the phencyclidine hyperlocomotion model.
Shu Q; Hu G; Li M
J Psychopharmacol; 2014 Apr; 28(4):363-75. PubMed ID: 24257809
[TBL] [Abstract][Full Text] [Related]
11. Sex differences in aripiprazole sensitization from adolescence to adulthood.
Freeman E; Lin J; Chow S; Davis C; Li M
Pharmacol Biochem Behav; 2017 May; 156():39-47. PubMed ID: 28389140
[TBL] [Abstract][Full Text] [Related]
12. Contextual and behavioral control of antipsychotic sensitization induced by haloperidol and olanzapine.
Zhang C; Li M
Behav Pharmacol; 2012 Feb; 23(1):66-79. PubMed ID: 22157143
[TBL] [Abstract][Full Text] [Related]
13. Differential effects of intermittent versus continuous haloperidol treatment throughout adolescence on haloperidol sensitization and social behavior in adulthood.
Gao J; Li M
Prog Neuropsychopharmacol Biol Psychiatry; 2014 Oct; 54():67-75. PubMed ID: 24942467
[TBL] [Abstract][Full Text] [Related]
14. The adenosine A(2A) receptor agonist CGS 21680 alleviates auditory sensorimotor gating deficits and increases in accumbal CREB in rats neonatally treated with quinpirole.
Brown RW; Bhide PG; Gill WD; Peeters LD
Psychopharmacology (Berl); 2020 Dec; 237(12):3519-3527. PubMed ID: 32772144
[TBL] [Abstract][Full Text] [Related]
15. Olanzapine and risperidone disrupt conditioned avoidance responding by selectively weakening motivational salience of conditioned stimulus: further evidence.
Zhang C; Fang Y; Li M
Pharmacol Biochem Behav; 2011 Mar; 98(1):155-60. PubMed ID: 21194545
[TBL] [Abstract][Full Text] [Related]
16. Repeated effects of the neurotensin receptor agonist PD149163 in three animal tests of antipsychotic activity: assessing for tolerance and cross-tolerance to clozapine.
Chou S; Davis C; Jones S; Li M
Pharmacol Biochem Behav; 2015 Jan; 128():78-88. PubMed ID: 25433325
[TBL] [Abstract][Full Text] [Related]
17. Time-dependent sensitization of antipsychotic effect in adolescent male and female rats.
Ding X; Li X; Shu Q; Wu R; Hu G; Li M
Behav Brain Res; 2017 Jun; 328():186-194. PubMed ID: 28412306
[TBL] [Abstract][Full Text] [Related]
18. Effects of central activation of serotonin 5-HT2A/2C or dopamine D 2/3 receptors on the acute and repeated effects of clozapine in the conditioned avoidance response test.
Feng M; Gao J; Sui N; Li M
Psychopharmacology (Berl); 2015 Apr; 232(7):1219-30. PubMed ID: 25288514
[TBL] [Abstract][Full Text] [Related]
19. Neonatal quinpirole treatment produces prepulse inhibition deficits in adult male and female rats.
Maple AM; Smith KJ; Perna MK; Brown RW
Pharmacol Biochem Behav; 2015 Oct; 137():93-100. PubMed ID: 26296939
[TBL] [Abstract][Full Text] [Related]
20. Modulation of mGlu5 improves sensorimotor gating deficits in rats neonatally treated with quinpirole through changes in dopamine D2 signaling.
Brown RW; Varnum CG; Wills LJ; Peeters LD; Gass JT
Pharmacol Biochem Behav; 2021 Dec; 211():173292. PubMed ID: 34710401
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
